Garosi LS, McConnell JF. Ischaemic stroke in dogs and humans: a comparative review. J Small Anim Pract. 2005;46(11):521–529.
Thomsen B, Garosi L, Skerritt G, et al. Neurological signs in 23 dogs with suspected rostral cerebellar ischaemic stroke. Acta Vet Scand. 2016;58(1):40. doi:10.1186/s13028-016-0219-2
Garosi L, McConnell JE, Platt SR, et al. Results of diagnostic investigations and long-term outcome of 33 dogs with brain infarction (2000–2004). J Vet Intern Med. 2005;19(5):725–731.
Boudreau CE. An update on cerebrovascular disease in dogs and cats. Vet Clin North Am Small Anim Pract. 2018;48(1):45–62.
Littman MP. Protein-losing nephropathy in small animals. Vet Clin North Am Small Anim Pract. 2011;41(1):31–62.
Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985–1992). J Am Anim Hosp Assoc. 1996;32(4):313–322.
Donahue SM, Brooks M, Otto CM. Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy. J Vet Emerg Crit Care (San Antonio). 2011;21(4):346–355.
IRIS Canine GN Study Group Standard Therapy Subgroup, Brown S, Elliott J, Francey T, Polzin D, Vaden S. Consensus recommendations for standard therapy of glomerular disease in dogs. J Vet Intern Med. 2013;27(suppl 1):S27–S43. doi:10.1111/jvim.12230
Klosterman ES, Moore GE, de Brito Galvao JF, et al. Comparison of signalment, clinicopathologic findings, histologic diagnosis, and prognosis in dogs with glomerular disease with or without nephrotic syndrome. J Vet Intern Med. 2011;25(2):206–214.
Advertisement
In collaboration with the American College of Veterinary Internal Medicine